T1	Participants 25 44	hairy cell leukemia
T2	Participants 61 108	cohort of 69 patients treated from 1983 to 1986
T3	Participants 146 260	69 hairy cell leukemia (HCL) patients treated with interferon alfa-2b (IFN) as primary treatment from 1983 to 1986
T4	Participants 262 291	Follow-up through April, 1993
